Clinical trial · Interventional
Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis
NCT04358666CI-TRIAL-00044804OPTMETACERunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Main Goal : evaluation of quality of life for patient having a brain metastasis and allowed to have either surgery and radiosurgery of the surgical site or only hypofractionned radiosurgery on the lesion. second objectives : evaluation of the local control of the disease evaluation of the overall survival interval without progression evaluation of the medico economic performance of each treatment protocol neuro cognitive evaluation at the end of the protocol
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Metastases | Brain Neoplasm | PROBABILISTIC | 0.70 |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| surgery and focal radiosurgery of the surgical bed | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- surgery and focal radiosurgery of the surgical site
- interventionNames
- Procedure: surgery and focal radiosurgery of the surgical bed
- type
- ACTIVE_COMPARATOR
- label
- hypofractionned radiosurgery
- interventionNames
- Procedure: surgery and focal radiosurgery of the surgical bed
Primary outcomes (1)
- measure
- quality of life EORTC QLQ C30
- timeFrame
- change between baseline and 6 month
- description
- score European Organisation for Research and Treatment of Cancer Quality Life Quotation C30
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * eligible for both treatments options OMS status \<3 primary cancer with no evolution brain metastasis \< 3cm ou giving symtoms patient with informed consent patient affilated to french social security Exclusion Criteria: * OMS \> 3 More than 3 brain metastasis brain metastasis already treated with hypofractionned radiosurgery
References
Publications (0)
Data not yet available
No reference posted for this study.